| A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer (NCT02567331) | Hoffmann-La Roche | 2004-10-01 |
| Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer (NCT00096330) | Roswell Park Cancer Institute | 2004-09-01 |
| Increasing Colorectal Cancer Screening Among Filipino Americans (NCT00742729) | Jonsson Comprehensive Cancer Center | 2004-09-01 |
| NGR-TNF in Treating Patients With Advanced Solid Tumors (NCT00098943) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-09-01 |
| Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00098982) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-09-01 |
| Computer-Based Tailored or Standard Information for Colorectal Cancer Screening (NCT00955188) | University of Michigan Rogel Cancer Center | 2004-08-01 |
| S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum (NCT00070434) | SWOG Cancer Research Network | 2004-08-01 |
| Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer (NCT00089635) | Amgen | 2004-08-01 |
| PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer (NCT00088413) | National Cancer Institute (NCI) | 2004-07-21 |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver (NCT00149396) | MediGene | 2004-07-01 |
| Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer (NCT00831181) | Beth Israel Medical Center | 2004-07-01 |
| Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer (NCT00058474) | NSABP Foundation Inc | 2004-07-01 |
| Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer (NCT00087256) | NSABP Foundation Inc | 2004-07-01 |
| Immune Response in Peripheral Blood of Patients With Colon Cancer (NCT00900432) | University of Arizona | 2004-07-01 |
| Vitamin D/Calcium Polyp Prevention Study (NCT00153816) | Dartmouth-Hitchcock Medical Center | 2004-07-01 |
| Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver (NCT00089401) | National Institutes of Health Clinical Center (CC) | 2004-07-01 |
| Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer (NCT00107315) | Roswell Park Cancer Institute | 2004-07-01 |
| Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib (NCT00820417) | Harrison Clinical Research | 2004-06-01 |
| Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer (NCT00444678) | NYU Langone Health | 2004-06-01 |
| Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00227734) | Swiss Cancer Institute | 2004-06-01 |
| Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer (NCT00091312) | Federation Francophone de Cancerologie Digestive | 2004-06-01 |
| Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer (NCT00220155) | Royal Marsden NHS Foundation Trust | 2004-05-01 |
| FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer (NCT00077337) | SWOG Cancer Research Network | 2004-04-01 |
| Intensified Chemotherapy in CRC After Resection of Liver Metastases (NCT00208260) | Institut du Cancer de Montpellier - Val d'Aurelle | 2004-04-01 |
| Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer (NCT00084773) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment (NCT00425204) | Amgen | 2004-03-01 |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer (NCT00081289) | Radiation Therapy Oncology Group | 2004-03-01 |
| Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy (NCT00083616) | Amgen | 2004-03-01 |
| Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon (NCT00085163) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-03-01 |
| Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer (NCT00159445) | University of Southern California | 2004-03-01 |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer (NCT00625625) | Saint John's Cancer Institute | 2004-03-01 |
| A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer (NCT00251485) | Veeda Oncology | 2004-03-01 |
| Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer (NCT00080951) | Alliance for Clinical Trials in Oncology | 2004-03-01 |
| GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer (NCT00262808) | University of Rochester | 2004-03-01 |
| A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma (NCT00097578) | Genentech, Inc. | 2004-03-01 |
| Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer (NCT00133913) | Immunicon | 2004-03-01 |
| A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) (NCT00709462) | Celldex Therapeutics | 2004-03-01 |
| Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer (NCT00560365) | University Hospital Southampton NHS Foundation Trust | 2004-03-01 |
| Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III (NCT00199654) | University Hospital, Limoges | 2004-02-01 |
| Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer (NCT00199862) | Memorial Sloan Kettering Cancer Center | 2004-02-01 |
| OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer (NCT00081237) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-02-01 |
| Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients (NCT00838318) | M.D. Anderson Cancer Center | 2004-02-01 |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma (NCT00080834) | Daiichi Sankyo | 2004-02-01 |
| Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer (NCT00079872) | Eli Lilly and Company | 2004-02-01 |
| IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure (NCT00242788) | AstraZeneca | 2004-02-01 |
| Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer (NCT00373022) | University of Arizona | 2004-01-01 |
| Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00274872) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2004-01-01 |
| Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer (NCT00291785) | CTI BioPharma | 2004-01-01 |
| Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III (NCT01196260) | State Key Laboratory of Cancer Biology | 2004-01-01 |
| Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer (NCT00113763) | Amgen | 2004-01-01 |
| Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients (NCT03337347) | The Institute of Molecular and Translational Medicine, Czech Republic | 2004-01-01 |
| Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer (NCT00209651) | Hokkaido Gastrointestinal Cancer Study Group | 2004-01-01 |
| Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer (NCT00087334) | Roswell Park Cancer Institute | 2004-01-01 |
| Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer (NCT00079066) | NCIC Clinical Trials Group | 2003-12-30 |
| Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight (NCT00303875) | Duke University | 2003-12-01 |
| FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum (NCT00077233) | Alliance for Clinical Trials in Oncology | 2003-12-01 |
| Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00280761) | UNC Lineberger Comprehensive Cancer Center | 2003-12-01 |
| Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients (NCT00228189) | Radboud University Medical Center | 2003-12-01 |
| Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer (NCT00075868) | Radiation Therapy Oncology Group | 2003-12-01 |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00084591) | Fox Chase Cancer Center | 2003-12-01 |
| Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy (NCT00812942) | Istituto Superiore di Sanità | 2003-11-01 |
| A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma (NCT00234429) | AstraZeneca | 2003-11-01 |
| Molecular Markers of Prognosis in Colorectal Cancer Patients (NCT00220142) | Royal Marsden NHS Foundation Trust | 2003-11-01 |
| Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants (NCT00087360) | Fox Chase Cancer Center | 2003-11-01 |
| Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer (NCT00077259) | Memorial Sloan Kettering Cancer Center | 2003-10-01 |
| A Longitudinal Investigation of Cognitive Function in Colorectal Cancer Patients (NCT01457287) | University Health Network, Toronto | 2003-10-01 |
| Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00086931) | Roswell Park Cancer Institute | 2003-09-01 |
| Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer (NCT00072098) | Max Sung | 2003-09-01 |
| Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer (NCT00416494) | Herbert Hurwitz, MD | 2003-09-01 |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer (NCT00899210) | University Hospital, Grenoble | 2003-09-01 |
| Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer (NCT00070213) | Medical Research Council | 2003-09-01 |
| Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer (NCT00072553) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2003-09-01 |
| Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT? (NCT00619814) | VA Caribbean Healthcare System | 2003-09-01 |
| Gene Expression Profiling in Normal Tissue and Tumor Tissue From Patients With Colon Cancer That Has Spread to the Liver, Lungs, or Peritoneum (NCT00896753) | Wake Forest University Health Sciences | 2003-09-01 |
| Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy (NCT00066846) | National Cancer Institute (NCI) | 2003-08-01 |
| Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer (NCT00063960) | Alliance for Clinical Trials in Oncology | 2003-08-01 |
| A Study of ABT-751 in Patients With Colorectal Cancer (NCT00073138) | Abbott | 2003-08-01 |
| A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer (NCT00069095) | Hoffmann-La Roche | 2003-07-01 |
| A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (NCT00069108) | Hoffmann-La Roche | 2003-07-01 |
| Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer (NCT00104689) | UNICANCER | 2003-06-30 |
| Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer (NCT00230399) | University of Michigan Rogel Cancer Center | 2003-06-01 |
| A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer (NCT00192075) | Eli Lilly and Company | 2003-06-01 |
| Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. (NCT00210106) | Institut Bergonié | 2003-06-01 |
| Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer (NCT00062023) | M.D. Anderson Cancer Center | 2003-06-01 |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer (NCT01016639) | Lund University Hospital | 2003-06-01 |
| Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia (NCT00611000) | Rockefeller University | 2003-06-01 |
| The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery (NCT00122720) | Herning Hospital | 2003-06-01 |
| Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age (NCT00173277) | National Taiwan University Hospital | 2003-06-01 |
| Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00303771) | Federation Francophone de Cancerologie Digestive | 2003-06-01 |
| Dissemination of Colorectal Cancer Screening to Primary Care Physicians (NCT00441311) | Columbia University | 2003-05-01 |
| Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia (NCT00043043) | National Cancer Institute (NCI) | 2003-05-01 |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer (NCT00062426) | Prologue Research International | 2003-05-01 |
| Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer (NCT00064181) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-05-01 |
| A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer (NCT00069121) | Hoffmann-La Roche | 2003-04-18 |
| Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer (NCT00280176) | UNC Lineberger Comprehensive Cancer Center | 2003-04-01 |
| Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer (NCT00410618) | University of Arizona | 2003-04-01 |
| Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer (NCT00063141) | Eli Lilly and Company | 2003-04-01 |
| Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins (NCT00131586) | AHS Cancer Control Alberta | 2003-04-01 |
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases (NCT00062348) | European Organisation for Research and Treatment of Cancer - EORTC | 2003-04-01 |
| Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer (NCT00091286) | Craig L Slingluff, Jr | 2003-03-24 |